Implexion Pharma develops innovative strategies to treat selected diseases by targeting gut microbial production of disease-causing substances. Implexion's first drug candidate is developed against the orphan drug-classified disease primary sclerosing cholangitis (PSC). Today there is no medical treatment for PSC and the patient needs liver transplantation to prevent premature death. Implexion's therapies have a unique opportunity to treat patients and prolong life, and we have treatments for several other indications in early pipeline.
| Website | https://implexion.se/ |
| Employees | 1 (0 on RocketReach) |
| Founded | 2019 |
| Industry | Biotechnology Research |
| Keywords | Orphan Drug Development, Microbiome Modulation, Rare Disease Treatment, Clinical Stage Drug, Biopharmaceutical Development, Drug Development Pipeline, Pharmaceutical Research, Targeted Therapies, Precision Medicine, Therapeutic Strategies, Biotechnology |
Looking for a particular Implexion Pharma employee's phone or email?
Implexion Pharma Questions
G2Crowd Trusted
300K+
Plugin Users
